BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 6352025)

  • 41. Preliminary study of effect of aspirin and dipyridamole on platelet adhesiveness and fibrinolytic activity in acute myocardial infarction.
    Jhawar BK; Trivedi HH; Bhargava RK; Misra NP
    J Assoc Physicians India; 1978 Sep; 26(9):805-9. PubMed ID: 370078
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of common antiplatelet drugs for vascular diseases.
    Pagano T; Nair CK; Sketch MH
    Geriatrics; 1983 Nov; 38(11):75-95. PubMed ID: 6605278
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hypercoagulability and cerebral infarction].
    Matsuda T
    No To Shinkei; 1986 Apr; 38(4):317-27. PubMed ID: 3013261
    [No Abstract]   [Full Text] [Related]  

  • 44. Antiplatelet agents: their role in the prevention of sudden death.
    Hirsh J
    Ann N Y Acad Sci; 1982; 382():289-304. PubMed ID: 7044244
    [No Abstract]   [Full Text] [Related]  

  • 45. [Antiplatelet drugs (author's transl)].
    Dechavanne M; Follea G; Trzeciak MC
    Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacology and pharmacokinetics of platelet-active drugs under current clinical investigation.
    FitzGerald GA; Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():107-72. PubMed ID: 6216780
    [No Abstract]   [Full Text] [Related]  

  • 47. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 48. [Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
    Loew D; Breddin K; Uberla K
    MMW Munch Med Wochenschr; 1982 Jan; 124(1):46-56. PubMed ID: 6120454
    [No Abstract]   [Full Text] [Related]  

  • 49. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 50. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
    Circulation; 1980 Sep; 62(3 Pt 2):II1-42. PubMed ID: 7408140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proceedings: A clinical trial of antiplatelet therapy in patients with coronary arterial disease.
    Michaels L; Galbraith PA; Ledwich JR
    Thromb Diath Haemorrh; 1975 Nov; 34(2):598-9. PubMed ID: 1105881
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiplatelet agents in prevention of myocardial infarction.
    Kshirsagar NA
    Indian Heart J; 1983; 35(1):60-6. PubMed ID: 6303947
    [No Abstract]   [Full Text] [Related]  

  • 54. Platelet tests and antiplatelet drugs in coronary artery disease.
    de Boer AC; Han P; Turpie AG; Butt R; Gent M; Genton E
    Circulation; 1983 Mar; 67(3):500-4. PubMed ID: 6217921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Controversy on platelet-inhibiting drugs].
    Oelz O
    Schweiz Med Wochenschr; 1985 May; 115(20):703-7. PubMed ID: 3892659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiplatelet drugs after acute myocardial infarction.
    Mannucci PM
    Ric Clin Lab; 1984; 14(1):1-7. PubMed ID: 6729352
    [No Abstract]   [Full Text] [Related]  

  • 57. Platelets.
    Hirsh J
    Can Med Assoc J; 1973 Feb; 108(4):416 passim. PubMed ID: 4687370
    [No Abstract]   [Full Text] [Related]  

  • 58. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 59. [Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
    Markiewicz M; Rymar B; Florkiewicz H; WysokiƄski A
    Pol Tyg Lek; 1983 Nov; 38(48):1501-3. PubMed ID: 6382203
    [No Abstract]   [Full Text] [Related]  

  • 60. Are agents affecting platelet function clinically useful in patients with coronary artery disease?
    Verstraete M
    Acta Clin Belg; 1976; 31(4):229-32. PubMed ID: 1087523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.